Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Nice end of the Day!!

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Oct 06, 2022 6:51pm

208 Views

Post# 35010946

RE:RE:RE:Nice end of the Day!!

If 60 to 65 thousand shares were bought at the close today, would you not think that this would affect the share price in a more dramatic uptick unless there is liquidity and people are just getting rid of shares or is it possible that onc is selling the ATM at this time. Sure would be nice to know. Bottom line is it is nice to see and increase in the volume now let's see if this carries through for another day and starts a trend.

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024